Windtree Therapeutics, Inc. (WINT)
OTCMKTS · Delayed Price · Currency is USD
0.0109
+0.0018 (19.78%)
At close: Feb 12, 2026
Windtree Therapeutics Market Cap
Windtree Therapeutics has a market cap or net worth of $445.56 thousand as of February 13, 2026. Its market cap has decreased by -71.78% in one year.
Market Cap
445.56K
Enterprise Value
3.73M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.01
Market Cap Chart
Since November 26, 1997, Windtree Therapeutics's market cap has decreased from 4.17B to 445.56K, a decrease of -99.99%. That is a compound annual growth rate of -27.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 445.56K | -61.50% |
| Dec 31, 2025 | 1.16M | -70.01% |
| Dec 31, 2024 | 3.86M | 4.27% |
| Dec 29, 2023 | 3.70M | -43.61% |
| Dec 30, 2022 | 6.56M | -85.53% |
| Dec 31, 2021 | 45.36M | -47.74% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sorrento Therapeutics | 706.83K |
| Helix BioMedix | 606.71K |
| Bio-Path Holdings | 536.05K |
| Innovation Pharmaceuticals | 528.77K |
| Regenerative Medical Technology Group | 515.05K |
| Avenue Therapeutics | 494.20K |
| Hepion Pharmaceuticals | 429.95K |
| Actavia Life Sciences | 385.91K |